Alcon Inc. Ordinary Shares (ALC) Stock: Buy, Sell, or Hold?
ALC - Alcon Inc. Ordinary Shares
$70.63
3.20 (4.75%)
▲
5d:
+6.08%
30d:
+8.01%
90d:
+4.01%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 10, 2026
17d
Get Alerted When ALC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ALC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ALC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$146.46
Based on 8.7% avg growth
INTRINSIC VALUE TODAY
$90.94
22.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALC is currently trading at $70.63, which is considered extended relative to its 30-day fair value range of $63.58 to $67.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.8) compared to its historical average (24.4). Remarkably, the market is currently pricing in an annual earnings decline of 10.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ALC is in a downtrend. The price is approaching resistance at $70.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.7% recently.
Market Sentiment: ALC scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $82.73 (+17.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALC is in a downtrend. The price is approaching resistance at $70.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.7% recently.
Market Sentiment: ALC scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $82.73 (+17.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$63.58 -
$67.03
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.2%
All Signals
- BEARISH: Price extended above range (+5.4% above its trading range)
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.7%)
- BULLISH: Trading below Wall St target ($82.73)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$63.58 -
$67.03
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$62.10
Resistance Level
$70.68
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.81
Wall Street Target
$82.73
(+17.1%)
Revenue Growth (YoY)
8.7%
Earnings Growth (YoY)
-44.6%
Profit Margin
5.9%
Valuation Discount vs History
-10.0% cheaper
PE vs Historical
17.8 vs 24.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.0%
(market-implied from PE analysis)
1-Year Target
$63.57
(-10%)
2-Year Target
$57.21
(-19%)
3-Year Target
$51.49
(-27%)
3-Yr Target (if PE normalizes)
(PE: 18→24)
$70.52
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 13.4%)
$114.75
(+63%)
Base:
(SPY PE: 17.8, Growth: 13.4%)
$102.94
(+46%)
Bear:
(PE: 15.1, Growth: 13.4%)
$87.50
(+24%)
📈
Valuation based on Current Earnings
Forward PE: 16.23 | Forward EPS (Implied): $4.35
Bull Case
$85.29
(+21%)
Analyst growth 15.0%, PE expands to 17.1
Base Case
$70.63
(0%)
Market implied 0.0%, PE stable at 16.2
Bear Case
$54.03
(-24%)
Severe decline -15.0%, PE contracts to 14.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.8 to 24.4
Stabilization Target:
$96.74
(+37.0%)
PE Expansion Potential:
+37.0%
Share & Embed Analysis
Last updated: October 23, 2026 1:53 AM ET
Data refreshes hourly during market hours. Next update: 2:53 AM
Data refreshes hourly during market hours. Next update: 2:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 32 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 49 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$413 | 41 HOLD |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 63 BUY |
|
NVST
Envista Holdings Corp |
BUY
15 analysts |
$29 | 68 BUY |
